# Effect of Hebal and Synthetic Medicamentss on Enterococcus Feacalis

> **NCT06006663** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Tanta University** · enrollment: 32 (estimated)

## Conditions studied

- Effective Intracanal Medicaments Against Enterococcus Faecalis

## Interventions

- **DRUG:** Ibuprofen 400 mg.
- **DRUG:** modified triple antibiotic paste
- **DIETARY_SUPPLEMENT:** curcumin
- **DIETARY_SUPPLEMENT:** olive leaves extract

## Key facts

- **NCT ID:** NCT06006663
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08-26
- **Primary completion:** 2023-10-05
- **Final completion:** 2023-12-10
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2023-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06006663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06006663, "Effect of Hebal and Synthetic Medicamentss on Enterococcus Feacalis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06006663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*